Ana D Thomas
Examiner (ID: 7472, Phone: (571)272-8549 , Office: P/3661 )
Most Active Art Unit | 3661 |
Art Unit(s) | 3661 |
Total Applications | 381 |
Issued Applications | 298 |
Pending Applications | 39 |
Abandoned Applications | 44 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18537395
[patent_doc_number] => 20230242487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => PURIFICATION OF BIS-QUATERNARY PYRIDINIUM OXIMES
[patent_app_type] => utility
[patent_app_number] => 17/649581
[patent_app_country] => US
[patent_app_date] => 2022-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2869
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17649581
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/649581 | PURIFICATION OF BIS-QUATERNARY PYRIDINIUM OXIMES | Jan 31, 2022 | Pending |
Array
(
[id] => 17611407
[patent_doc_number] => 20220153686
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => LIPID NANOPARTICLE COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/586488
[patent_app_country] => US
[patent_app_date] => 2022-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58495
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17586488
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/586488 | Lipid nanoparticle composition | Jan 26, 2022 | Issued |
Array
(
[id] => 18298126
[patent_doc_number] => 20230107812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => HALOGENATED BENZYLIDINE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/584189
[patent_app_country] => US
[patent_app_date] => 2022-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9127
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17584189
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/584189 | HALOGENATED BENZYLIDINE DERIVATIVES | Jan 24, 2022 | Pending |
Array
(
[id] => 18511276
[patent_doc_number] => 20230227410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => TETRAHYDROQUINOLINE DERIVATIVES AND A PROCESS OF PREPARATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/577217
[patent_app_country] => US
[patent_app_date] => 2022-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8528
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17577217
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/577217 | TETRAHYDROQUINOLINE DERIVATIVES AND A PROCESS OF PREPARATION THEREOF | Jan 16, 2022 | Abandoned |
Array
(
[id] => 17720366
[patent_doc_number] => 20220213086
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => AZOLE COMPOUNDS AS IRAK INHIBITORS, PREPARATION METHODS AND MEDICINAL USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/561894
[patent_app_country] => US
[patent_app_date] => 2021-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12720
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 407
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17561894
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/561894 | AZOLE COMPOUNDS AS IRAK INHIBITORS, PREPARATION METHODS AND MEDICINAL USES THEREOF | Dec 23, 2021 | Abandoned |
Array
(
[id] => 17896948
[patent_doc_number] => 20220306610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => COMPOUNDS USEFUL FOR TREATING GASTROINTESTINAL TRACT DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/558227
[patent_app_country] => US
[patent_app_date] => 2021-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 88522
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17558227
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/558227 | COMPOUNDS USEFUL FOR TREATING GASTROINTESTINAL TRACT DISORDERS | Dec 20, 2021 | Abandoned |
Array
(
[id] => 17687607
[patent_doc_number] => 20220194899
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => HIGHLY PURIFIED BATCHES OF PHARMACEUTICAL GRADE 1-DEOXYGALACTONOJIRIMYCIN COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/551806
[patent_app_country] => US
[patent_app_date] => 2021-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57817
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17551806
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/551806 | Highly purified batches of pharmaceutical grade 1-deoxygalactonojirimycin compounds | Dec 14, 2021 | Issued |
Array
(
[id] => 17734652
[patent_doc_number] => 20220220111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => 1,8-NAPHTHYRIDINONE COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/644052
[patent_app_country] => US
[patent_app_date] => 2021-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37157
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17644052
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/644052 | 1,8-NAPHTHYRIDINONE COMPOUNDS AND USES THEREOF | Dec 12, 2021 | Abandoned |
Array
(
[id] => 17480488
[patent_doc_number] => 20220087992
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => COMPOUNDS AND METHODS OF TREATING RETINAL DEGENERATION
[patent_app_type] => utility
[patent_app_number] => 17/544454
[patent_app_country] => US
[patent_app_date] => 2021-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25718
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 209
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17544454
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/544454 | Compounds and methods of treating retinal degeneration | Dec 6, 2021 | Issued |
Array
(
[id] => 18980097
[patent_doc_number] => 11905257
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-20
[patent_title] => Manufacturing process for preparing gadoteridol
[patent_app_type] => utility
[patent_app_number] => 18/039540
[patent_app_country] => US
[patent_app_date] => 2021-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 3759
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18039540
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/039540 | Manufacturing process for preparing gadoteridol | Nov 30, 2021 | Issued |
Array
(
[id] => 17640565
[patent_doc_number] => 20220168303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => TREATMENT OF HER2 POSITIVE CANCERS
[patent_app_type] => utility
[patent_app_number] => 17/530265
[patent_app_country] => US
[patent_app_date] => 2021-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31362
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17530265
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/530265 | Treatment of HER2 positive cancers | Nov 17, 2021 | Issued |
Array
(
[id] => 17460163
[patent_doc_number] => 20220073468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => N-ALKYLATION OF ACRIDANS
[patent_app_type] => utility
[patent_app_number] => 17/454916
[patent_app_country] => US
[patent_app_date] => 2021-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9998
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17454916
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/454916 | N-ALKYLATION OF ACRIDANS | Nov 14, 2021 | Pending |
Array
(
[id] => 17482045
[patent_doc_number] => 20220089549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => INHIBITORS OF PROTEIN ARGININE DEIMINASES (PADS) AND METHODS OF PREPARATION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/520603
[patent_app_country] => US
[patent_app_date] => 2021-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30550
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17520603
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/520603 | INHIBITORS OF PROTEIN ARGININE DEIMINASES (PADS) AND METHODS OF PREPARATION AND USE THEREOF | Nov 4, 2021 | Pending |
Array
(
[id] => 17413958
[patent_doc_number] => 20220048862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => High-Purity Quinoline Derivative and Method for Manufacturing Same
[patent_app_type] => utility
[patent_app_number] => 17/511773
[patent_app_country] => US
[patent_app_date] => 2021-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9707
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17511773
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/511773 | High-Purity Quinoline Derivative and Method for Manufacturing Same | Oct 26, 2021 | Pending |
Array
(
[id] => 17656969
[patent_doc_number] => 20220177434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X2 AND RELATED PRODUCTS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/506447
[patent_app_country] => US
[patent_app_date] => 2021-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22010
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17506447
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/506447 | Modulators of mas-related G-protein receptor X2 and related products and methods | Oct 19, 2021 | Issued |
Array
(
[id] => 17761392
[patent_doc_number] => 20220235004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => PARA ACYL SUBSTITUTED DIAZACYCLOHEXENE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/499728
[patent_app_country] => US
[patent_app_date] => 2021-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3619
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17499728
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/499728 | Para acyl substituted diazacyclohexene derivatives | Oct 11, 2021 | Issued |
Array
(
[id] => 17368232
[patent_doc_number] => 20220023284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => Processes for Preparing Quinoline Compounds and Pharmaceutical Compositions Containing Such Compounds
[patent_app_type] => utility
[patent_app_number] => 17/497201
[patent_app_country] => US
[patent_app_date] => 2021-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10541
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17497201
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/497201 | Processes for Preparing Quinoline Compounds and Pharmaceutical Compositions Containing Such Compounds | Oct 7, 2021 | Abandoned |
Array
(
[id] => 17563082
[patent_doc_number] => 20220127231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => PROCESS FOR THE PREPARTION OF AMIFAMPRIDINE PHOSPHATE
[patent_app_type] => utility
[patent_app_number] => 17/474087
[patent_app_country] => US
[patent_app_date] => 2021-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3954
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17474087
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/474087 | PROCESS FOR THE PREPARTION OF AMIFAMPRIDINE PHOSPHATE | Sep 13, 2021 | Abandoned |
Array
(
[id] => 18254252
[patent_doc_number] => 20230081291
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => QUINOLINE cGAS ANTAGONIST COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/446951
[patent_app_country] => US
[patent_app_date] => 2021-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67232
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17446951
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/446951 | Quinoline cGAS antagonist compounds | Sep 2, 2021 | Issued |
Array
(
[id] => 17687610
[patent_doc_number] => 20220194902
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => Method of Preparing Fluorine-18 Labeled Cabozantinib and Its Analogs
[patent_app_type] => utility
[patent_app_number] => 17/466328
[patent_app_country] => US
[patent_app_date] => 2021-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11341
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17466328
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/466328 | Method of Preparing Fluorine-18 Labeled Cabozantinib and Its Analogs | Sep 2, 2021 | Abandoned |